USA - NASDAQ:MRAI - US5713542083 - Common Stock
The current stock price of MRAI is 0.9 USD. In the past month the price decreased by -56.52%. In the past year, price decreased by -65.89%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| MMC | MARSH & MCLENNAN COS | 18.8 | 87.48B | ||
| AON | AON PLC-CLASS A | 20.12 | 70.73B | ||
| AJG | ARTHUR J GALLAGHER & CO | 25.21 | 67.16B | ||
| WTW | WILLIS TOWERS WATSON PLC | 18.54 | 30.84B | ||
| BRO | BROWN & BROWN INC | 18.99 | 26.50B | ||
| RYAN | RYAN SPECIALTY HOLDINGS INC | 26.54 | 13.37B | ||
| HGTY | HAGERTY INC-A | 39.82 | 3.81B | ||
| BWIN | BALDWIN INSURANCE GROUP INC/ | 12.83 | 2.54B | ||
| GSHD | GOOSEHEAD INSURANCE INC -A | 33.81 | 2.54B | ||
| ABLLL | ABACUS GLOBAL MGMT INC - ABL 9 7/8 11/15/28 | 33.22 | 2.59B | ||
| ARX | ACCELERANT HOLDINGS-CL A | 57.15 | 2.51B | ||
| YB | YUANBAO INC -ADR | 4.53 | 996.05M |
Marpai Inc is a US-based company operating in Insurance industry. The company is headquartered in Tampa, Florida and currently employs 303 full-time employees. The company went IPO on 2021-10-27. Marpai, Inc. is a technology-driven healthcare company, which uses artificial intelligence (AI) and data analytics. The firm provides administrative services and acts as a third-party administrator (TPA) to self-insured employers who provide healthcare benefits to their employees. The Company’s clients are small and medium-sized companies, as well as local government entities. The company provides services to a total of over 41,000 of its client’s employees, including their spouses and dependents. The company serves a total of approximately 73,000 members in 44 states in addition to the District of Columbia. The Company’s AI-powered TopCare program became live, making it possible for it to offer care management with predictions. The Company’s wholly owned subsidiaries include Marpai Captive, Inc., Marpai Administrators, LLC, Marpai Health, Inc., EYME Technologies, Ltd. and Maestro Health, LLC.
MARPAI INC-CLASS A
615 Channelside Drive, Suite 207
Tampa FLORIDA US
Employees: 303
Phone: 16463033483
Marpai Inc is a US-based company operating in Insurance industry. The company is headquartered in Tampa, Florida and currently employs 303 full-time employees. The company went IPO on 2021-10-27. Marpai, Inc. is a technology-driven healthcare company, which uses artificial intelligence (AI) and data analytics. The firm provides administrative services and acts as a third-party administrator (TPA) to self-insured employers who provide healthcare benefits to their employees. The Company’s clients are small and medium-sized companies, as well as local government entities. The company provides services to a total of over 41,000 of its client’s employees, including their spouses and dependents. The company serves a total of approximately 73,000 members in 44 states in addition to the District of Columbia. The Company’s AI-powered TopCare program became live, making it possible for it to offer care management with predictions. The Company’s wholly owned subsidiaries include Marpai Captive, Inc., Marpai Administrators, LLC, Marpai Health, Inc., EYME Technologies, Ltd. and Maestro Health, LLC.
The current stock price of MRAI is 0.9 USD. The price decreased by -53.61% in the last trading session.
MRAI does not pay a dividend.
MRAI has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
MARPAI INC-CLASS A (MRAI) does not have a PE ratio as the earnings reported over the last twelve months were negative (-3.16).
MARPAI INC-CLASS A (MRAI) has a market capitalization of 9.28M USD. This makes MRAI a Nano Cap stock.
You can find the ownership structure of MARPAI INC-CLASS A (MRAI) on the Ownership tab.
ChartMill assigns a fundamental rating of 2 / 10 to MRAI. Both the profitability and financial health of MRAI have multiple concerns.
Over the last trailing twelve months MRAI reported a non-GAAP Earnings per Share(EPS) of -3.16. The EPS increased by 45.44% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -80.54% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
7 analysts have analysed MRAI and the average price target is 6.12 USD. This implies a price increase of 580% is expected in the next year compared to the current price of 0.9.
For the next year, analysts expect an EPS growth of 66.51% and a revenue growth -2.59% for MRAI